Even, the solution for medication-induced nutrient depletions (MIND), has announced its brand launch and $1.5 million seed funding led by Align Ventures, Spring Street Group and GAN Ventures.
“In my 13 years of working with patients, I heard the same side effects over and over from patients using certain medications,” said Sarah Morgan, Co-Founder & CEO of Even. “Once I looked into their bloodwork, a pattern emerged: the same glaring nutrient depletions and biochemical imbalances appeared in patients using the same medications. We’ve heard the patients, done the research, and put in the work knowing millions of people can take the medications they need while avoiding nutrient depletions and corresponding symptoms.”
Even’s nutrient repletion systems are designed to address Medication-Induced Nutrient Depletions (M.I.N.D.) and mitigate potential side effects of antidepressants, birth control, and statins related to nutrient deficiencies.
The brand offers medical foods backed by medication-nutrient research, and designed by a team of physicians, nutritionists and pharmacists. Co-founded by CEO Sarah Morgan and Grant Hosking, Even claims to be on a mission to enrich medication users’ daily quality of life.
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.